DFJ leads Verge Genomics' $32M series A round

Neuroscience company Verge Genomics Inc. (San Francisco, Calif.) raised $32 million in a series A round

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE